The NIH and DOE have collaborated to develop additional X-ray beamlines at Argonne National Laboratory, enhancing structural biology research. Researchers can now conduct studies from home laboratories with the aid of automated tools, leading to improved data quality and discovery.
Researchers discovered genetic variations in the VKORC1 gene that affect warfarin dosing, allowing for more precise patient treatment. The study, supported by the NIH Pharmacogenetics Research Network, may enable doctors to set ideal doses quickly and precisely.
The National Institute of General Medical Sciences (NIGMS) funded a 10-year project to determine the shapes of proteins found in nature. The pilot phase yielded over 1,000 protein structures, transforming structure determination from manual to highly automated processes.
The Center for Quantitative Biology aims to tackle complex biological questions using advanced computing, microscopy, and gene chips. It will train future research leaders through a new undergraduate and graduate curriculum.
The MIDAS (Mathematical Information Domain for Assessment of Substantial Threats) project will create mathematical models to study infectious disease epidemics and community responses. The project, funded by the NIH, will provide user-friendly computer modeling tools for predicting and responding to bioterror threats.
Scientists use 'targeted mutagenesis' to make proteins more amenable to crystallization, shedding light on the plague and other diseases. The technique has already solved the structures of stubborn proteins like V antigen of Yersinia pestis.
Two new centers will explore modular biology and biological circuits in human cells, aiming to unravel complex patterns of biological interactions. Researchers from diverse fields will work together to solve today's most challenging problems in biomedicine.
The consortium aims to identify and measure all lipid types within a cell, improving understanding of their role in diseases. This knowledge will help develop more effective diagnostic devices and treatments for conditions like cardiovascular disease and inflammatory disorders.
Scientists have determined the structure of the 2G12 antibody, which neutralizes HIV by binding to sugars on its surface. The antibody's unique structure could provide a template for designing an antigen that triggers the body to produce it, potentially leading to an HIV vaccine.
Scientists have discovered an unusual protein structure, known as a 'knot', which defies traditional understanding of protein folding. The newly found knot may stabilize amino acid subunits in the protein, shedding light on its mysterious function and potential applications in disease diagnosis and drug development.
The NIGMS initiative supports two Centers of Excellence in Chemical Methodologies and Library Development, focusing on high-throughput technologies to generate customized libraries. Researchers at Boston University and University of Pittsburgh will develop novel methods for synthesizing complex molecules and peptide mimetics.
The partnership aims to advance biomedical research through collaboration between biologists and mathematicians/scientists. The new awards will support projects in areas such as disease modeling, HIV dynamics, and bioinformatics.
The National Institute of General Medical Sciences (NIGMS) is supporting the construction of four new 900 MHz NMR magnets, the largest size available. This funding will enable researchers to study the structure and behavior of biological molecules, revealing insights into normal cellular processes and shedding light on diseases.
The NIH is funding three new synchrotron beamlines at Argonne National Laboratory to aid in the structural study of biological molecules. These facilities will be used to analyze protein structures that can help develop targeted cancer treatments.
Dr. K. Barry Sharpless' discovery of chiral catalysts has enabled the production of useful molecules, including therapeutics that improve human health and lives. His work has streamlined the creation of important chemicals, including antibiotics and heart medicines.
Leland Hartwell received the Nobel Prize for his work on cell cycle control, discovering over 100 genes involved in regulating cell division. His research has led to a deeper understanding of normal cellular function and the molecular basis of diseases like cancer.
The NIGMS Structural Genomics Awards will support seven research centers in determining the structures of thousands of proteins over the next decade. The project aims to advance our understanding of biological processes and develop new treatments for diseases.
The Alliance for Cellular Signaling project will study cellular communications in cardiomyocytes and B-cells using a mouse model system. The goal is to map out signals and develop a virtual cell that can be used for drug testing, with the ultimate aim of transforming cell signaling research.
Scientists have developed a method to 'knock out' fruit fly genes, allowing researchers to study their functions and identify corresponding human diseases. The technique, also applicable to fixing faulty genes, has the potential to revolutionize gene therapy.
The NIH has awarded nine grants totaling $12.8 million to investigate the role of genetics in determining how medicines work in the human body and what side effects people may experience. These studies aim to develop more personalized medicine approaches through pharmacogenetics research.
Researchers have developed an automated approach to identify which molecules in a cell physically interact with each other, a crucial task for understanding life's functions. The new method enables scientists to track the 'conversations' between thousands of molecules simultaneously.
Günter Blobel's work on protein signaling discovered the importance of signal sequences in targeting proteins to their proper intracellular destinations. His research has led to a deeper understanding of protein trafficking, with implications for drug delivery and cellular processes.
Researchers have identified a new molecular marker for Alzheimer's disease, a normal cellular enzyme called casein kinase-1 (CK-1), which accumulates in nerve cells damaged by AD. CK-1 levels were found to be abnormally high in vacuoles within the hippocampus region of AD brains.
For the first time, researchers have designed a working molecular motor that can convert chemical energy into controlled motion. This breakthrough advances miniaturization technology to the single molecule level, with potential applications in understanding diseases and developing new treatments.
A new study reveals that genetic mechanisms controlling the biological clock are also involved in cocaine sensitization in fruit flies. The research provides valuable insights into the development of treatments for cocaine addiction and may lead to discoveries about other physiological processes controlled by so-called 'clock' genes.
Researchers uncover crucial role of copper chaperone in delivering copper to superoxide dismutase enzyme, a key player in treating Lou Gehrig's disease. The study reveals the structure of the yeast copper chaperone protein, which helps protect copper from unwanted cellular interactions.
Recent discoveries in circadian rhythms research have identified a set of probably a dozen or so proteins that regulate the biological clock in flies and mammals. These proteins share a common molecular motif called the PAS domain, which instructs them to attach to other proteins and help set the clock's time.
Scientists have uncovered a genetic cause for urinary tract disorders, linking GATA-2 protein to proper genitourinary tract development. The finding paves the way for diagnostic and treatment strategies for bladder and kidney disorders in newborns.
Researchers have discovered plant glutamate receptors, which work similarly to human receptors in the brain. This finding suggests that plants possess a signaling system for neurotransmitters, enabling potential use as a model system to study neurological functions.
Researchers found that ultraviolet light triggers a harmful chemical reaction in the skin, leading to premature aging and cancer. The study reveals that a natural component of human skin, previously thought to be a 'nature's sunscreen,' actually contributes to skin damage.
Researchers have discovered that a molecule called Noggin plays a crucial role in forming the brains of frogs and the elbows of mice. The study reveals that Noggin helps regulate cellular growth factors to promote proper tissue development, and its absence leads to severe skeletal defects and joint abnormalities.
The National Institute of General Medical Sciences (NIGMS) has awarded $2 million to support 20 grants from the first round of applications. The grants focus on high-impact, high-risk research studies in areas such as cell biology, biophysics, and pharmacology.
Scientists have determined the 3D molecular structure of HIV's nucleocapsid protein, which recognizes and binds to viral RNA. This discovery may lead to the development of highly specific anti-AIDS drugs that can prevent HIV spread and be safe for patients.
Researchers at the University of Virginia have discovered that fruit flies respond to cocaine in a similar manner as humans, using similar biochemical pathways. This breakthrough may lead to highly specific drugs to treat cocaine addiction, based on genetic and biochemical insights gained from studying the flies.
Dr. Paul D. Boyer, a long-time NIH grantee, has won the Nobel Prize in Chemistry for his groundbreaking work on ATP synthesis. His research has provided a deep understanding of the molecular mechanism by which ATP is formed, shedding light on fundamental processes in biology.
Research reveals grapefruit juice increases CYP3A4 enzyme levels, affecting drug metabolism; this finding narrows the search for responsible substance, enabling safer medications. Consistency is key: individuals taking affected drugs should consult physicians if adding grapefruit juice to their diet.
Researchers at Brown University have discovered a novel method for delivering drugs orally using tiny, biocompatible beads that stick to intestinal tissues and slowly erode to release drugs. The technique has shown promise in treating inflammatory bowel disorders such as ulcerative colitis and Crohn's disease.
Scientists at UC Berkeley designed a protein that toggles between two structures upon binding a small molecule, enabling detection of carcinogens like benzene. The newly designed protein could also be used as a molecular switch or zipper to join proteins together.
Scientists have detailed the structure of yeast topoisomerase II, a key player in cell division. This knowledge could lead to the development of new anticancer drugs that target this enzyme. The discovery also has implications for the design of antimicrobial drugs and the treatment of cancer.
Scientists have long known that proteins like colicin Ia can punch holes in cell membranes to kill bacteria. Researchers at Albert Einstein College of Medicine mapped the structure of colicin Ia, revealing a massive chunk of protein must cross the membrane to form an open channel.